The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement.

The menopause, or the cessation of menstruation, is a stage of the life cycle which will occur in all women. Managing perimenopausal and postmenopausal health is a key issue for all areas of healthcare, not just gynecology. To provide recommendations for the curriculum of education programs for healthcare professionals worldwide, so that all can receive high quality training on menopause. Literature review and consensus of expert opinion. Training programs for healthcare professionals worldwide should include menopause and postmenopausal health in their curriculum. It should include assessment, diagnosis and evidence-based management strategies.

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Margaret Rees has received consulting fees in the past 3 years from Sojournix, Inc. Kathy Abernethy: None declared Gloria Bachmann: None declared Silvia Bretz: None declared Iuliana Ceausu: None declared. Fatih Durmusoglu: None declared. Risto Erkkola: None declared. Ivan Fistonic: has received consulting fees in the past 3 years from Fotona Inc. Marco Gambacciani: has received speaker and consulting fees in the past 3 years from MSD, Theramex and Bayer Marije Geukes: None declared Dimitrios G. Goulis: None declared. Amanda Griffiths: None declared Haitham Hamoda: None declared Claire Hardy: is director of the workplace consultancy company Hardy People Ltd. Caiomhe Hartley: None declared Angelica Lindén Hirschberg in the past 3 years has received grant support from ITF Research Pharma for the "Blissafe study" Angela Kydd: None declared Skye Marshall: None declared Blazej Meczekalski: None declared Nicolas Mendoza in the past 3 years has received grant support from Astellas Pharma. Alfred Mueck: None declared Emma Persand: None declared Kathleen Riach: None declared Antonina Smetnik: none declared Petra Stute has received speaker and consulting fees in the past 3 years from Besins Healthcare, Jenapharm GmbH & Co. KG, Labatec Pharma SA, Effik SA, Astellas Pharma AG and Viatris Mick van Trotsenburg: None declared. Nese Yuksel has received speaker and/or advisory board fees in the past 3 years from Biosyent, Pfizer and Amgen. Rachel Weiss is the chair of Menopause Café® www.menopausecafe.net. Irene Lambrinoudaki: None declared.